VLA 0.00% $1.75 viralytics limited

VLA AGM Presentation, page-41

  1. 1,269 Posts.
    lightbulb Created with Sketch. 46
    After all this time VLA is still stuck at completing existing 1b combination trials and are planning to start more 1b trials.

    Maybe VLA management is lousy at recruiting patients? I don't know why they are taking forever to recruit, but no patients =no results = no viable biotech business.

    Super-slow recruitment = slow result reporting = painful biotech business
    Last edited by hotcongo: 23/11/17
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.